Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kaddurah-Daouk

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|April 15, 2015
Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision MedicineR Kaddurah-Daouk, R Weinshilboum,
Physiological Reviews|July 14, 2000
Creatine and creatinine metabolismM Wyss, R Kaddurah-Daouk
Clinical Pharmacology and Therapeutics|November 7, 2013
Pharmacometabolomics: implications for clinical pharmacology and systems pharmacologyR Kaddurah-Daouk, R M Weinshilboum,
The Journal of Biological Chemistry|December 5, 1985
Purification of the HhaII restriction endonuclease from an overproducer Escherichia coli cloneS Kelly, R Kaddurah-Daouk, H O Smith
Brain Research|March 23, 2000
Neuroprotective effects of creatine administration against NMDA and malonate toxicityC Malcon, R Kaddurah-Daouk, M F Beal
The Journal of Biological Chemistry|December 5, 1985
Catalytic properties of the HhaII restriction endonucleaseR Kaddurah-Daouk, P Cho, H O Smith
Clinical Pharmacology and Therapeutics|August 16, 2013
Pharmacometabolomics of statin responseR M Krauss, H Zhu, R Kaddurah-Daouk
Cancer Research|October 1, 1994
Cell cycle studies of cyclocreatine, a new anticancer agentK J Martin, E R Winslow, R Kaddurah-Daouk
Journal of Molecular and Cellular Cardiology|April 1, 1996
Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamstersR Tian, L Nascimben, R Kaddurah-Daouk, et al.
In Vivo (Athens, Greece)|June 17, 1998
Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolismG Ara, L M Gravelin, R Kaddurah-Daouk, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|April 15, 2015
Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision MedicineR Kaddurah-Daouk, R Weinshilboum,
Physiological Reviews|July 14, 2000
Creatine and creatinine metabolismM Wyss, R Kaddurah-Daouk
Clinical Pharmacology and Therapeutics|November 7, 2013
Pharmacometabolomics: implications for clinical pharmacology and systems pharmacologyR Kaddurah-Daouk, R M Weinshilboum,
The Journal of Biological Chemistry|December 5, 1985
Purification of the HhaII restriction endonuclease from an overproducer Escherichia coli cloneS Kelly, R Kaddurah-Daouk, H O Smith
Brain Research|March 23, 2000
Neuroprotective effects of creatine administration against NMDA and malonate toxicityC Malcon, R Kaddurah-Daouk, M F Beal
The Journal of Biological Chemistry|December 5, 1985
Catalytic properties of the HhaII restriction endonucleaseR Kaddurah-Daouk, P Cho, H O Smith
Clinical Pharmacology and Therapeutics|August 16, 2013
Pharmacometabolomics of statin responseR M Krauss, H Zhu, R Kaddurah-Daouk
Cancer Research|October 1, 1994
Cell cycle studies of cyclocreatine, a new anticancer agentK J Martin, E R Winslow, R Kaddurah-Daouk
Journal of Molecular and Cellular Cardiology|April 1, 1996
Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamstersR Tian, L Nascimben, R Kaddurah-Daouk, et al.
In Vivo (Athens, Greece)|June 17, 1998
Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolismG Ara, L M Gravelin, R Kaddurah-Daouk, et al.
Pageof 5